Correction: Fahmy et al. PEGylated Chitosan Nanoparticles Encapsulating Ascorbic Acid and Oxaliplatin Exhibit Dramatic Apoptotic Effects against Breast Cancer Cells. Pharmaceutics 2022, 14, 407

Key Points

• To investigate the apoptotic effects of PEGylated chitosan nanoparticles encapsulating ascorbic acid and oxaliplatin on breast cancer cells.
• Nanoformulation of PEGylated chitosan nanoparticles
• In vitro testing on breast cancer cell lines
• Assessment of apoptosis induction through biochemical assays.
• PEGylated chitosan nanoparticles significantly increased apoptosis in breast cancer cells.
• Encapsulation of ascorbic acid and oxaliplatin enhanced the therapeutic efficacy.
• Comparison to non-encapsulated treatments showed marked improvements.